Cardiovascular Function and Physical Activity in COVID-19
NCT ID: NCT05492552
Last Updated: 2023-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
124 participants
INTERVENTIONAL
2022-04-07
2023-05-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Moderate Exercise Training on Vitals and Peak VO2 in Different Age Categories of Adult in COVID-19.
NCT04927182
COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)
NCT04595773
COVID-19 Research: COPE Trial in Health Care Workers
NCT05271006
Physical Activity and the Risk of COVID-19 Infection and Mortality
NCT04631861
Effects of Different Moderate-intensity Exercise Methods on Health in the Elderly
NCT05207501
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-COVID participants
No interventions assigned to this group
COVID participants in intervention
The intervention group will attend the laboratory for baseline testing and complete a week of usual daily activity. Following this week they will then be guided to increase their daily step count by 2,000 and supported through weekly telephone calls.
Active-at-home-HF
Increase daily step count by 2,000 and weekly telephone calls.
COVID participants assigned to usual daily activity
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active-at-home-HF
Increase daily step count by 2,000 and weekly telephone calls.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Up to date with all COVID-19 vaccinations
* COVID participants - had a positive test for COVID-19 over 28 days of initial visit but before 18 months. Non-COVID participants - never received a positive COVID-19 test result, and no symptoms during periods where testing was unavailable.
Exclusion Criteria
* Severe hypertension
* Acute or chronic neurological impairment or progressive neurological disease
* Use of medication known to directly affect cardiac function
* Current smoker
* Body mass index \> 35 kg/m2
* People who exceed current physical activity guidelines defined by the World Health Organization (WHO).
50 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coventry University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Djordje Jakovljevic
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coventry University
Coventry, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rahman M, Russell SL, Okwose NC, Hood OMA, Harwood AE, McGregor G, Raleigh SM, Sandhu H, Roden LC, Maddock H, Banerjee P, Jakovljevic DG. Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial. Trials. 2023 May 13;24(1):328. doi: 10.1186/s13063-023-07360-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P125303
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.